158-OR: Major Adverse Cardiovascular Events for Kidney Disease Patients Treated with Metformin or Sulfonylurea

Background: Safety concerns limit metformin use in kidney disease. We compared major adverse cardiovascular events (MACE) for metformin or sulfonylureas users with reduced glomerular filtration rate (GFR). Methods: A retrospective cohort combined Veterans Administration, Medicare, and National Death...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2019-06, Vol.68 (Supplement_1)
Hauptverfasser:	ROUMIE, CHRISTIANNE, CHIPMAN, JONATHAN J., MIN, JEA YOUNG, HUNG, ADRIANA M., HACKSTADT, AMBER J., GREEVY, ROBERT A., GRIJALVA, CARLOS G., ELASY, TOM, GRIFFIN, MARIE R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidiabetics Cerebral infarction Creatinine Death Glomerular filtration rate Ischemia Kidney diseases Metformin Myocardial infarction Sulfonylurea Transient ischemic attack
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!